Phibro Animal Health Statistics
Total Valuation
PAHC has a market cap or net worth of $1.59 billion. The enterprise value is $2.29 billion.
| Market Cap | 1.59B |
| Enterprise Value | 2.29B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Nov 26, 2025 |
Share Statistics
PAHC has 40.53 million shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | 20.45M |
| Shares Outstanding | 40.53M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 49.61% |
| Owned by Institutions (%) | 50.11% |
| Float | 20.31M |
Valuation Ratios
The trailing PE ratio is 23.44 and the forward PE ratio is 14.04. PAHC's PEG ratio is 0.89.
| PE Ratio | 23.44 |
| Forward PE | 14.04 |
| PS Ratio | 1.13 |
| Forward PS | n/a |
| PB Ratio | 5.09 |
| P/TBV Ratio | 7.31 |
| P/FCF Ratio | 46.29 |
| P/OCF Ratio | 20.67 |
| PEG Ratio | 0.89 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.96, with an EV/FCF ratio of 66.79.
| EV / Earnings | 33.77 |
| EV / Sales | 1.64 |
| EV / EBITDA | 10.96 |
| EV / EBIT | 14.23 |
| EV / FCF | 66.79 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 2.53.
| Current Ratio | 3.09 |
| Quick Ratio | 1.12 |
| Debt / Equity | 2.53 |
| Debt / EBITDA | 3.54 |
| Debt / FCF | 23.00 |
| Interest Coverage | 3.93 |
Financial Efficiency
Return on equity (ROE) is 23.79% and return on invested capital (ROIC) is 10.74%.
| Return on Equity (ROE) | 23.79% |
| Return on Assets (ROA) | 8.55% |
| Return on Invested Capital (ROIC) | 10.74% |
| Return on Capital Employed (ROCE) | 14.43% |
| Revenue Per Employee | $565,526 |
| Profits Per Employee | $27,400 |
| Employee Count | 2,475 |
| Asset Turnover | 1.19 |
| Inventory Turnover | 2.57 |
Taxes
In the past 12 months, PAHC has paid $26.82 million in taxes.
| Income Tax | 26.82M |
| Effective Tax Rate | 28.34% |
Stock Price Statistics
The stock price has increased by +65.72% in the last 52 weeks. The beta is 0.77, so PAHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +65.72% |
| 50-Day Moving Average | 41.11 |
| 200-Day Moving Average | 30.02 |
| Relative Strength Index (RSI) | 39.14 |
| Average Volume (20 Days) | 316,928 |
Short Selling Information
The latest short interest is 919,138, so 2.27% of the outstanding shares have been sold short.
| Short Interest | 919,138 |
| Short Previous Month | 929,598 |
| Short % of Shares Out | 2.27% |
| Short % of Float | 4.53% |
| Short Ratio (days to cover) | 3.03 |
Income Statement
In the last 12 months, PAHC had revenue of $1.40 billion and earned $67.82 million in profits. Earnings per share was $1.67.
| Revenue | 1.40B |
| Gross Profit | 443.03M |
| Operating Income | 160.94M |
| Pretax Income | 94.64M |
| Net Income | 67.82M |
| EBITDA | 208.95M |
| EBIT | 160.94M |
| Earnings Per Share (EPS) | $1.67 |
Balance Sheet
The company has $85.89 million in cash and $788.52 million in debt, giving a net cash position of -$702.63 million or -$17.33 per share.
| Cash & Cash Equivalents | 85.89M |
| Total Debt | 788.52M |
| Net Cash | -702.63M |
| Net Cash Per Share | -$17.33 |
| Equity (Book Value) | 311.68M |
| Book Value Per Share | 7.69 |
| Working Capital | 565.66M |
Cash Flow
In the last 12 months, operating cash flow was $76.80 million and capital expenditures -$42.52 million, giving a free cash flow of $34.29 million.
| Operating Cash Flow | 76.80M |
| Capital Expenditures | -42.52M |
| Free Cash Flow | 34.29M |
| FCF Per Share | $0.85 |
Margins
Gross margin is 31.65%, with operating and profit margins of 11.50% and 4.85%.
| Gross Margin | 31.65% |
| Operating Margin | 11.50% |
| Pretax Margin | 6.76% |
| Profit Margin | 4.85% |
| EBITDA Margin | 14.93% |
| EBIT Margin | 11.50% |
| FCF Margin | 2.45% |
Dividends & Yields
This stock pays an annual dividend of $0.48, which amounts to a dividend yield of 1.23%.
| Dividend Per Share | $0.48 |
| Dividend Yield | 1.23% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 28.73% |
| Buyback Yield | -0.52% |
| Shareholder Yield | 0.71% |
| Earnings Yield | 4.27% |
| FCF Yield | 2.16% |
Analyst Forecast
The average price target for PAHC is $31.25, which is -20.20% lower than the current price. The consensus rating is "Hold".
| Price Target | $31.25 |
| Price Target Difference | -20.20% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PAHC has an Altman Z-Score of 2.75 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 6 |